Login
$PRGO
$16.18 +$0.00 (0.0%) After hours

$PRGO 8-K SEC Filings

Filed On Filing
04 Nov 2026 8-K: Results of Operations and Financial Condition

DUBLIN, November 4, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of consumer self-care products, today announced financial results from continuing operations for the third quarter...

29 Oct 2026 8-K: Regulation FD Disclosure

Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMade  Advances Streamline pillar of Perrigo’s Three-S plan through portfolio simplification  Furthers Perrigo’s evolution into a simpler, more focused consumer se...

05 Aug 2026 8-K: Results of Operations and Financial Condition

DUBLIN, August 5, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced financial results from continuing operations for the second quarter ...

06 Jul 2026 8-K: Departure/Election of Directors or Officers; Compensation

On June 29, 2026, the Company reinstated the Perrigo Company plc Executive Committee Severance Policy, as amended and restated (the “Executive Severance Policy”) which previously terminated effective January 15, 2020. Each of the Company...

30 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Dublin, Ireland – June 30, 2026 – Perrigo Company plc (NYSE: PRGO) ("Perrigo"), a leading provider of consumer health products, today announced that its Board of Directors has appointed Salman Amin and Omer Gajial as independent director...

08 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Patrick Lockwood-Taylor Resigns as President and CEO and as a Member of the Board

06 May 2026 8-K: Results of Operations and Financial Condition

DUBLIN, May 6, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced financial results from continuing operations for the first quarter ende...

05 May 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

SECTION 1. PURPOSE. Perrigo Company plc, a public limited company headquartered in Ireland, has adopted the Perrigo Company plc 2026 Long-Term Incentive Plan (including the appendices hereto, the “2026 Plan” or the “Plan”) to encourage e...

30 Apr 2026 8-K: Completion of Acquisition or Disposition of Assets; Regulation FD Disclosure

�  �  !"#$$%&'&()*+),-./0 1 23.45*$&678,&97-./:;2<./ 23 =9>?@>9A9BC"D@'E9>9F@=B?GH2 /.1 .4I;2<./ HG< 2.J4I.2/HG: 2JKHL/�;2HI .4/MJ4<.2 N;/J4 // '...

22 Apr 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

(1) During the three months ended March 29, 2025, we determined the carrying value of the Richard Bittner Business net assets held for sale exceeded their fair value less costs to sell, resulting in a total impairment charge of $3.1 mill...

23 Mar 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

Exhibit 10.1 Execution Version Deal CUSIP Number: 71429TAA8 Revolving Facility CUSIP Number: 71429TAG5 Term B Facility CUSIP Number: 71429TAF7 AMENDED AND RESTATED CREDIT AGREEMENT dated as of March 20, 2026 among PERRIGO COMPANY PLC, as...

26 Feb 2026 8-K: Results of Operations and Financial Condition

Delivered FY2025 Adj. EPS at the Midpoint of Updated Outlook Range

05 Nov 2025 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Amid Soft Market Consumption Trends, Achieved Q3 2025 Dollar, Unit and Volume Share(1) Gains in 5 of 7 Over-The-Counter (“OTC”) Store Brand Categories and Dollar Share Gains in Key Brands

06 Aug 2025 8-K: Results of Operations and Financial Condition

Company Advanced its ‘Three-S’ Plan (Stabilize, Streamline, and Strengthen) with Recently Announced Agreement to Sell Dermacosmetics Business, Scaling of Global Operating Growth Model, and Upgraded Brand Building Capabilities that are De...

14 Jul 2025 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

for the sale and purchase of certain parts of Perrigo’s European skin care business

01 Jul 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Company to Scale and Optimize Global Category-Led, Market Activation Growth Model

04 Jun 2025 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

Perrigo Corporation DAC whose registered address is at The Sharp Building, Hogan Place, Dublin 2 (the Company); and

07 May 2025 8-K: Results of Operations and Financial Condition

Advancing 'Three-S' Plan to Stabilize, Streamline and Strengthen Perrigo, which was Detailed at February 2025 Investor Day

05 May 2025 8-K: Submission of Matters to a Vote of Security Holders

At the Company's Annual General Meeting of Shareholders held on May 1, 2025, the Company's shareholders voted on the following matters:

27 Feb 2025 8-K: Results of Operations and Financial Condition

Making Significant Progress on Stabilizing, Streamlining and Strengthening Organization to Build Long-Term Sustainable, Value Accretive Growth

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support